Transplantation of other extrarenal organs followed close behind the liver, using similar immunosuppression. Hearts were successfully transplanted in 1968 in Capetown by Barnard [62] and in Palo Alto by Shumway [63]. In 1969, the first prolonged survival after human lung [64] and pancreas transplantation [65] was accomplished in Ghent and Minneapolis, respectively. But transplantation of the extra-renal organs, and especially of the liver, remained controversial for another decade, because of the high mortality. Swimming against the stream, the German and French teams of Rudolf Pichlmayr and Henri Bismuth entered the field in the early 1970s, as did the Dutch group of Rudi Krom later in the decade.
The unusual tolerogenicity of the hepatic allograft previously demonstrated in dogs and pigs was evident in human liver recipients of the 1970s. In 1995, 12 of our 42 patients (28%) surviving from this era already had been off all immunosuppression for 1–17 years [66,67]. Since then, many of the remaining 30, who are now out to 45 years post-transplantation, also have stopped drugs and remain well. Such drug-free tolerance was almost unheard of with the other kinds of cadaveric organs.
28.8.1 Advent of better drugs
Despite such encouraging notations, the widespread use of the liver and other extrarenal organs was precluded for another decade by the high mortality. The outlook for all organs improved after cyclosporine was introduced clinically in England in 1978 by Calne [68] and combined with prednisone in Denver 1 year later [69]. Results further improved when tacrolimus was substituted for cyclosporine in the 1990s [70,71].
The increases in liver recipient survival with the two new drugs were particularly striking, but less dramatic gains were recorded with the other organs. By the end of the twentieth century, transplantation of the liver and all of the other vital organs had become an integral part of sophisticated medical practice in every developed country in the world.
The lesson is clear. History is neither dull nor dead. It is a uniquely human survival tool, aiding those in the present by the ability to draw on the past to meet current needs, and to predict needs yet to come.
Thomas E. Starzl
Liver transplantation … was a therapeutic modality for end-stage liver disease that deserves broader application.
NIH Consensus Development Conference on Liver Transplantation, 1983
1. Brent L. A History of Transplantation Immunology. Academic Press, London, 1997.
2. Hamilton D. A History of Organ Transplantation. University of Pittsburgh Press, Pittsburgh, PA, 2012.
3. Welch CS. A note on transplantation of the whole liver in dogs. Transplantation Bulletin 1955; 2: 54–55.
4. Goodrich EO Jr, Welch HF, Nelson IA, et al. Homotransplantation of the canine liver. Surgery 1956; 39: 244–251.
5. Meyer WH Jr, Starzl TE. The reverse portacaval shunt. Surgery 1959; 45: 531–534.
6. Meyer WH Jr, Starzl TE. The effect of Eck and reverse Eck fistula in dogs with experimental diabetes mellitus. Surgery 1959; 45: 760–764.
7. Starzl TE, Bernhard VM, Benvenuto R, Cortes N. A new method for one-stage hepatectomy in dogs. Surgery 1959; 46: 880–886.
8. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Annals of Surgery 1989; 210: 649–652.
9. Starzl TE, Kaupp HA Jr, Brock DR, et al. Reconstructive problems in canine liver homotrans-plantation with special reference to the postoperative role of hepatic venous flow. Surgery, Gynecology and Obstetrics 1960; 111: 733–743.
10. Cannon IA, Longmire WP. Studies of successful skin homografts in the chicken. Annals of Surgery 1952; 135: 60–68.
11. Cannon JA. Brief report. Transplantation Bulletin 1956; 3: 7.
12. Moore FD, Smith LL, Burnap TK, et al. One-stage homotransplantation of the liver following total hepatectomy in dogs. Transplantation Bulletin 1959; 6: 103–110.
13. Moore FD, Wheeler HB, Demissianos HV, et al. Experimental whole organ transplantation of the liver and of the spleen. Annals of Surgery 1960; 152: 374–385; discussion 386.
14. Lillehei RC, Goott B, Miller LB. The physiologic response of the small bowel of the dog to ischemia including prolonged in vitro preservation of the bowel with successful replacement and survival. Annals of Surgery 1959; 150: 543–560.
15. Lower RR, Shumway NE. Studies in orthotopic homo-transplantation of the canine heart. Surgical Forum 1960; 11: 18–19.